Studying neuropathic pain in humans has major ethical and experimental limitations. The use of alternate mammalian animal models has been the solution for many years. For both human and animal studies scientists had to rely frequently on behavioral tests that may not directly reflect the experience the animal is going through.
Thus, this may be one of the reasons because our ability to treat pain symptoms still relies on a small number of drugs. This suggests that the use of other model systems may help to discovery new compounds with potential analgesic activity.
A new published study in Journal of Cellular Physiology by a team led by Dr. Antonio Giordano and Dr. Gianfranco Bellipanni of Sbarro Institute for Cancer Research and Molecular Medicine and Temple University (Philadelphia, USA) adds a new prospective on the research on pain perception. They used larvae of the small vertebrate zebrafish to show that at the molecular level they respond to stimuli that induce inflammation and axons degenerations similarly to mammals.
“We found the highest temperature zebrafish larvae could survive and exposed them for only 5 seconds, the results where similar to human severe skin burns. “ Dr. Giordano said. “ Then we went to see if the panel of genes, activated by pain in humans, was activated also in the fish. Interestingly, they were activated at the right place and time”.
We asked Dr. Gianfranco Bellipanni to explain how this research could have implications for humans: “to understand better the mechanism of neuropathic pain and to discovery new drugs first we need an animal model that is easy and economic to keep, that shows a high degree of similarity in pain perception and response with mammals and is especially able to offer many technical tools for conducting studies.
Zebrafish matches all these characteristics” he said. “ Now we are creating transgenic zebrafish that became fluorescent in response to painful stimulations. These transgenic fish can be used for in vivo studies. At first we will use these transgenic fish to characterize better the cellular and molecular mechanisms of pain, but our final goal, if we will find the appropriate funding, is to use them for screening for chemicals with potential analgesic activity”.
Other authors of the study include Dr. Valentina Malafoglia and William Raffaeli both at ISAL-Foundation, Institute for Research on Pain, Dr. Marco Colasanti at University of Roma3 and Dr. Darius Balciunas at Temple University.
Dr. Antonio Giordano is Director and Founder of Sbarro Health Research Organization at Philadelphia, PA (www.shro.org) and Professor of Pathology and Oncology at University of Siena, Italy.
Barbara Colombo | Newswise
Not of Divided Mind
19.01.2017 | Hertie-Institut für klinische Hirnforschung (HIH)
CRISPR meets single-cell sequencing in new screening method
19.01.2017 | CeMM Forschungszentrum für Molekulare Medizin der Österreichischen Akademie der Wissenschaften
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
19.01.2017 | Earth Sciences
19.01.2017 | Life Sciences
19.01.2017 | Physics and Astronomy